Guru Ownership Trend
Guru Analysis for Atrium Therapeutics, Inc. (RNA)
Atrium Therapeutics, Inc. (RNA), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 2 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $2.62 M.
Top institutional holders include Cliff Asness and Renaissance Technologies (RenTech).
Institutional sentiment is currently Bullish. This is evidenced by a $2.01 M net inflow during the quarter.
Recent activity highlights Cliff Asness who opened a new position.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Atrium Therapeutics, Inc. (RNA)
Major holders include Cliff Asness ($2.32 M), Renaissance Technologies (RenTech) ($201,360). According to the latest reported data, 2 tracked investment managers collectively hold approximately 187,206 shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $2.01 M, with 2 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 0 managers trimmed their positions, while 2 fully exited RNA. The total reported sell value was $510,092.
Yes, 2 managers opened new positions in RNA, and 0 increased their existing holdings. The total reported buy value was $2.52 M.